ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia.

Jun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.